Human Papillomavirus Vaccines
11
0
0
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
9.1%
1 terminated out of 11 trials
87.5%
+1.0% vs benchmark
18%
2 trials in Phase 3/4
57%
4 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (11)
HPV Vaccine Communication ECHO for Primary Care Clinics
HPV Vaccine Confident Families
Increasing Optimal Use of HPV Vaccination in Primary Care
Immunogenicity and Safety of One Dose of HPV Vaccine
Community Pharmacists Vaccinate Against Cancer
Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial
Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents
A Multicenter Cohort Study Assessing the Efficacy and Adverse Effects of HPV Vaccination in Chinese Women
Study on the Epidemiological Characteristics of Female HPV Vaccination in China
Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination
Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9